Integrating Cancer Control Referrals and Navigators Into United Way 211 Missouri
NCT ID: NCT01027741
Last Updated: 2018-05-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
4762 participants
INTERVENTIONAL
2009-12-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. estimate the prevalence of need for cancer screening and prevention in a population of 211 callers;
2. determine whether cancer communication interventions delivered through 211 can increase use of breast, cervical and colon cancer screening, HPV vaccination, smoking cessation and adoption of smoke free home policies;
3. determine how intensive an intervention is needed to bring about these changes; and
4. determine whether the effectiveness of these interventions is enhanced when callers' basic needs have been addressed. Connecting these systems - 211, clinical and community cancer control programs and navigation services - should benefit disadvantaged Americans. The proposed study will evaluate the effects of this approach to eliminating cancer disparities.
We hypothesize that the proportion of 211 callers who obtain a needed cancer control service will:
1. differ significantly by study group as follows: N \> T \> P \> CONTROL;
2. vary significantly across study groups based on the intervention dose callers receive; and
3. vary significantly across study groups based on whether callers' original need was resolved, the extent of their basic needs, and their perception of life as manageable and predictable (i.e., sense of coherence).
(Dissemination Aim): Determine costs to 211 and effects on quality of service by offering cancer control referrals.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Cancer Prevention and Control Through Academic-local Public Health Department Partnerships
NCT06605196
Telephone-Based Decision Support for Rural Patients
NCT01217333
Facilitating Web-based Patient Decision Support: Decision About Medication to Lower Breast Cancer Risk
NCT00906321
Design of Chatbot Persona for Breast Cancer Screening Outreach Among Black Women
NCT05472064
A Study of a Distress Screening and Referral Program in People With Recently Diagnosed Cancer
NCT07117461
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The proposed study will:
1. estimate the prevalence of need for cancer screening and prevention in a population of 211 callers;
2. determine whether cancer communication interventions delivered through 211 can increase use of breast, cervical and colon cancer screening, HPV vaccination, smoking cessation and adoption of smoke free home policies;
3. determine how intensive an intervention is needed to bring about these changes; and
4. determine whether the effectiveness of these interventions is enhanced when callers' basic needs have been addressed. Connecting these systems - 211, clinical and community cancer control programs and navigation services - should benefit disadvantaged Americans. The proposed study will evaluate the effects of this approach to eliminating cancer disparities.
Objectives:
Study group assignment -- By random assignment they will then receive either:
* Tailored Cancer Communication to help them act on the cancer control referral they received;
* A Cancer Control Navigator to help them overcome obstacles to obtaining needed cancer control services;
* Cancer Control Phone Referral Only; or,
* No intervention control
The study aims are to:
1. Estimate the prevalence of need for cancer screening and prevention in a population of 211 callers and compare these rates to population data from Missouri and the U.S.
2. Evaluate effects of Tailored Cancer Communication (T), Cancer Control Navigation (N), Cancer Control Phone Referral Only (P) on use of cancer control services in a randomized trial among 211 callers.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phone Referral
Participants receive phone referral to cancer control and prevention services.
Phone Referral
Participants receive phone referral to cancer control and prevention services.
Tailored Cancer Communication
Participants will receive phone referral to cancer control and prevention services as well as tailored materials in the mail.
Phone Referral
Participants receive phone referral to cancer control and prevention services.
Tailored Cancer Communication
Mailed material with messages tailored to participant's age, gender, race/ethnicity, whether he or she has kids in the home, reason for calling 211, and cancer control need.
Cancer Control Navigator
Participants will receive phone referral to cancer control and prevention services as well as a personal cancer control navigator.
Phone Referral
Participants receive phone referral to cancer control and prevention services.
Cancer Control Navigator
A cancer control navigator is assigned to each participant. This navigator helps the participant make and keep cancer control and prevention appointments, as well as providing resources and guidance to help address participant barriers to use of needed cancer control and prevention services. Intervention is phone-based.
Control
Participants receive only recommendation to talk to health care professional.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phone Referral
Participants receive phone referral to cancer control and prevention services.
Tailored Cancer Communication
Mailed material with messages tailored to participant's age, gender, race/ethnicity, whether he or she has kids in the home, reason for calling 211, and cancer control need.
Cancer Control Navigator
A cancer control navigator is assigned to each participant. This navigator helps the participant make and keep cancer control and prevention appointments, as well as providing resources and guidance to help address participant barriers to use of needed cancer control and prevention services. Intervention is phone-based.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* caller to 211 who was randomly allocated to one of two study-specific information specialists
* resident of Missouri
* calling for unmet needs for self
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United Way Missouri
UNKNOWN
Washington University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthew W Kreuter, PhD, MPH
Role: PRINCIPAL_INVESTIGATOR
Washington University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Washington University in St. Louis
St Louis, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
000708
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.